Skip to content

Improving mobility in diabetic patients through resistance training

Improving mobility in diabetic patients through resistance training - n.v.t.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON34079
Enrollment
180
Registered
2006-06-12
Start date
2006-07-01
Completion date
Unknown
Last updated
2024-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polyneuropathy

Interventions

once a plenary training session of 1,5 hour provided by a physical therapist. And 2 trainings sessions of half an hour each, by them selves at home.
During 24 weeks, the patients of the intervention group will participate in a resistance training program. Two subsequent intervention programmes will be offered. Initially the first 12 week resista
subsequently a more extended programme affecting total limb musculature (lower- and upper leg) will be provided (also 12 weeks). During these trainings period, patients will train 3 times a week

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: diabetic patients with polyneuropathy: valkscore >5; diabetic type 2; age >50 years;, 2050 years; 2050 years, 20

Exclusion criteria

Exclusion criteria: muscular related diseases ischemia amputation (except for toe amputation)

Design outcomes

Primary

MeasureTime frame
Muscle strength in the leg: the strength of the plantar- and dorsalfelxors and for the knee and hip extensors and flexors will be determined. Fysical activity: during one week, the daily activity will be determined using an accelerometer. Mobility: this will be determined using a questionnaire and a 6 minutes walking test. Gait analysis: walking patterns will be analysed using video analysis and the force plait.

Secondary

MeasureTime frame
Quality of life wil be measured using a questionnaire. Difficulty in Activities of daily living Tasks (DAT) will be determined using EMG during a 6 minutes walking test.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)